| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 31.572 | 45.026 | 26.140 | 18.591 | 16.282 | 5.654 | 14.638 | 1.169 | 10.796 | - |
| Total Income - EUR | 31.572 | 45.161 | 26.274 | 18.591 | 16.289 | 5.663 | 14.729 | 1.219 | 10.828 | - |
| Total Expenses - EUR | 59.939 | 46.480 | 36.028 | 27.512 | 25.889 | 12.496 | 14.652 | 7.257 | 9.683 | - |
| Gross Profit/Loss - EUR | -28.367 | -1.318 | -9.754 | -8.920 | -9.600 | -6.832 | 77 | -6.038 | 1.146 | - |
| Net Profit/Loss - EUR | -29.314 | -2.220 | -10.538 | -9.479 | -10.042 | -6.987 | -362 | -6.073 | 1.029 | - |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Punta Pharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.093 | 19.540 | 12.194 | 4.441 | 631 | 28 | 216 | 412 | 338 | - |
| Current Assets | 20.683 | 43.184 | 38.986 | 31.631 | 38.872 | 31.465 | 40.410 | 38.438 | 51.175 | - |
| Inventories | 4.447 | 4.962 | 6.786 | 84 | 8.540 | 9.184 | 19.692 | 19.328 | 26.866 | - |
| Receivables | 15.988 | 31.651 | 27.910 | 26.206 | 30.130 | 21.873 | 20.497 | 19.038 | 23.297 | - |
| Cash | 248 | 6.571 | 4.290 | 5.342 | 202 | 408 | 221 | 72 | 1.012 | - |
| Shareholders Funds | -28.812 | -30.738 | -40.756 | -49.487 | -57.433 | -63.331 | -62.289 | -68.555 | -67.318 | - |
| Social Capital | 1.215 | 1.202 | 1.182 | 1.160 | 2.276 | 2.233 | 2.183 | 2.190 | 2.183 | - |
| Debts | 62.282 | 93.440 | 91.915 | 85.299 | 97.255 | 95.136 | 103.216 | 107.844 | 119.206 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Punta Pharm S.r.l.